Interview with
Quarterly Updates
Crystal Research Associates provides its clients with four updates following the release of quarterly financial results. These are concise summaries of each company's performance during the previous quarter, combined with a listing of key accomplishments during that timeframe. Similar in structure to the EIO's, quarterly updates include the following:
- Important announcements
- Updated financial data
- Key points for investors to consider
- Important quarterly developments/news
- Company Focus
Currently Crystal Research Associates provides quarterly updates for: Accelr8 Technology Corporation, Advanced Cell Technology, Aeterna Zentaris, Amarin Corporation, Antares Pharma, ConjuChem, CoTherix, Crucell N.V., Cytocore, Cytomedix, DermWorx, Dimethaid Research, DOR BioPharma, Electronic Sensor Technology, Gentium, HemoBioTech, Immune Response Corp, Inksure Technologies, Innovative Card Technologies, Isonics, LAB International, Lorus Therapeutics, Medgenics, Medical Nutrition USA, MIGENIX, Millennium Biotech Group, MIV Therapeutics, MultiCell Technologies, NaviSite, Neah Power Systems, New Century Companies, Norwood Abbey, Opexa Therapeutics (formerly PharmaFronties), Pluristem Life Systems, Pro-Pharmaceuticals, Procyon Biopharma, ProMetic Life Sciences, Protein Polymer Technologies, Provectus Pharmaceuticals, Refocus Group, Roadhouse Foods, Synthetic Blood International, Technest Holdings, Quigley Corp, Topo-Target A/S, Unigene Laboratories, Vena Resources, ViRexx Medical, WorldWater & Power and XOMA.